Cargando…
Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients
Breast cancer has become the most common cancer that leads to women’s death. Breast cancer is a complex, highly heterogeneous disease classified into various subtypes based on histological features, which determines the therapeutic options. System identification of effective drugs for each subtype r...
Autores principales: | Xu, Yingqi, Lin, Shuting, Zhao, Hongying, Wang, Jingwen, Zhang, Chunlong, Dong, Qun, Hu, Congxue, Shang, Desi, Wang, Li, Xu, Yanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770221/ https://www.ncbi.nlm.nih.gov/pubmed/31466383 http://dx.doi.org/10.3390/genes10090657 |
Ejemplares similares
-
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019) -
Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2022) -
Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma
por: Wang, Jingwen, et al.
Publicado: (2021) -
Identification of miRNA-Mediated Core Gene Module for Glioma Patient Prediction by Integrating High-Throughput miRNA, mRNA Expression and Pathway Structure
por: Zhang, Chunlong, et al.
Publicado: (2014) -
Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies
por: Feng, Li, et al.
Publicado: (2015)